Skip To Content Table Of Contents
Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site
Substance Dependence, Abuse and Treatment

Appendix B: Statistical Methods and Limitations of the Data

B.1 Target Population

An important limitation of the National Household Survey on Drug Abuse (NHSDA) estimates of drug use prevalence is that they are only designed to describe the target population of the survey—the civilian, noninstitutionalized population aged 12 or older. Although this population includes almost 98 percent of the total U.S. population aged 12 or older, it excludes some important and unique subpopulations who may have very different drug-using patterns. For example, the survey excludes active military personnel, who have been shown to have significantly lower rates of illicit drug use. Persons living in institutional group quarters, such as prisons and residential drug treatment centers, are not included in the NHSDA and have been shown in other surveys to have higher rates of illicit drug use. Also excluded are homeless persons not living in a shelter on the survey date, another population shown to have higher than average rates of illicit drug use. Appendix D describes other surveys that provide data for these populations.

B.2 Sampling Error and Statistical Significance

The sampling error of an estimate is the error caused by the selection of a sample instead of conducting a census of the population. Sampling error is reduced by selecting a large sample and by using efficient sample design and estimation strategies, such as stratification, optimal allocation, and ratio estimation.

With the use of probability sampling methods in the NHSDA, it is possible to develop estimates of sampling error from the survey data. These estimates have been calculated for all estimates presented in this report using a Taylor series linearization approach that takes into account the effects of the complex NHSDA design features. The sampling errors are used to identify unreliable estimates and to test for the statistical significance of differences between estimates.

B.2.1 Variance Estimation for Totals

Estimates of proportions, such as drug use prevalence rates, take the form of nonlinear statistics where the variances cannot be expressed in closed form. Variance estimation for nonlinear statistics is performed using a first-order Taylor series approximation in the SUrvey DAta ANalysis (SUDAAN) statistical software package developed by RTI (Shah, Barnwell, & Bieler, 1996). The approximation is unbiased for sufficiently large samples and has proven to beat least as accurate and less costly to implement than its competitors, such as balanced repeated replication or jackknife methods (Rao & Wu, 1985).

Corresponding to proportion estimates, , the number of drug users, Yd , can be estimated as

where is the estimated population total for domain d, and is the estimated proportion for domain d. The standard error (SE) for the total estimate is obtained by multiplying the SE of the proportion by , that is,

 .

This approach is theoretically correct when the domain size estimates are among those forced to Census Bureau population projections through the weight calibration process. In these cases, is clearly not subject to sampling error.

For domain totals Yd where is not fixed, this formulation may still provide a good approximation if we can reasonably assume that the sampling variation in is negligible relative to the sampling variation in . In most analyses conducted for prior years, this has been a reasonable assumption. SUDAAN also provides an option to directly estimate the variance of the linear statistic that estimates a population total. Using this option did not affect the standard error (SE) estimates for the corresponding proportions presented in the same sets of tables.

B.2.2 Suppression Criteria for Unreliable Estimates

As has been done in past NHSDA reports, direct survey estimates considered to be unreliable due to unacceptably large sampling errors are not shown in this report and are noted by asterisks (*) in the tables containing such estimates found in the appendices. The criterion used for suppressing all direct survey estimates was based on the relative standard error (RSE), which is defined as the ratio of the SE over the estimate.

Proportion estimates (p) within the range [0<p<1], rates, and corresponding estimated number of users were suppressed if

RSE[-ln(p)] > 0.175 when p < 0.5

or

RSE[-ln(1 - p)] > 0.175 when p > 0.5 .

Using a first-order Taylor series approximation to estimate RSE[-ln(p)] and RSE[-ln(1 - p)], we have the following, which was used for computational purposes:

[SE(p)/p ÷ -1n( p)] > 0.175 when p < 0.5

or

[SE(p)/(1-p) ÷ -1n(1 - p)] > 0.175 when p > 0.5 .

The separate formulas for p < 0.5 and p > 0.5 produce a symmetric suppression rule; that is, if p is suppressed, then so will 1 - p. This is an ad hoc rule that requires an effective sample size in excess of 50. When 0.05 < p < 0.95, the symmetric properties of the rule produces a local maximum effective sample size of 68 at p = 0.5. Thus, estimates with these values of p along with effective sample sizes falling below 68 are suppressed. A local minimum effective sample size of 50 occurs at p = 0.2 and again at p = 0.8 within this same interval; so, estimates are suppressed for values of p with effective sample sizes below 50.

In NHSDAs prior to the 2000 NHSDA, these varying sample size restrictions sometimes produced unusual occurrences of suppression for a particular combination of prevalence rates. For example, in some cases, lifetime prevalence rates near p = 0.5 were suppressed (effective sample size was <68 but >50), while not suppressing the corresponding past year or past month estimates near p = 0.2 (effective sample sizes were >50). To reduce the occurrence of this type of inconsistency, a minimum effective sample size of 68 was added to the suppression criteria. As p approached 0.00 or 1.00 outside the interval (0.05, 0.95), the suppression criteria still required increasingly larger effective sample sizes. For example, if p = 0.01 and 0.001, the effective sample size must exceed 152 and 684, respectively.

Also new to the 2000 survey were minimum nominal sample size suppression criteria (n = 100) that protect against unreliable estimates caused by small design effects and small nominal sample sizes. Prevalence estimates were also suppressed if they were close to 0 or 100 percent (i.e., if p < 0.00005 or if p > 0.99995). Estimates of other totals (e.g., number of initiates) along with means and rates (both not bounded between 0 and 1) were suppressed if RSE(p) > 0.5. Additionally, estimates of the mean age at first use were suppressed if the sample size was smaller than 10 respondents; moreover, the estimated incidence rate and number of initiates were suppressed if they rounded to 0. The suppression criteria for various NHSDA estimates are summarized in Table B.1.

 

Table B.1. Summary of 2000 NHSDA Suppression Rules

Estimate

Suppress if:

Prevalence rate, p, with nominal sample size, n, and design effect, deff

The estimated prevalence rate, p, is < 0.00005 or >0.99995, or

when p < 0.5, or

when p > 0.5, or

Effective n < 68, or

n < 100

where

Note: The rounding portion of this suppression rule for prevalence rates will produce some estimates that round at one decimal place to 0.0% or 100.0% but are not suppressed from the tables.

Estimated number
(numerator of p)

The estimated prevalence rate, p, is suppressed.

Note: In some instances when p is not suppressed, the estimated number may appear as a 0 in the tables; this means that the estimate is >0 but <500 (estimated numbers are shown in thousands).

Mean age at first use, , with nominal sample size, n

, or
n < 10

Incidence rate,

Rounds to < 0.1 per 1,000 person-years of exposure, or

Number of initiates, 

Rounds to < 1,000 initiates, or

Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 1999 and 2000.

B.3 Nonsampling Error

Nonsampling errors can occur from nonresponse, coding errors, computer processing errors, errors in the sampling frame, reporting errors, and other errors not due to sampling. Nonsampling errors are reduced through data editing, statistical adjustments for nonresponse, close monitoring and periodic retraining of interviewers, and improvement in various quality control procedures.

Although nonsampling errors can often be much larger than sampling errors, measurement of most nonsampling errors is difficult or impossible. However, some indication of the effects of some types of nonsampling errors can be obtained through proxy measures, such as response rates and from other research studies.

B.3.1 Screening and Interview Response Rate Patterns

Response rates for the NHSDA were stable for the period from 1994 to 1998, with the screening response rate at about 93 percent and the interview response rate at about 78 percent (response rates discussed in this appendix are weighted). In 1999, the computer-assisted interviewing (CAI) screening response rate was 89.6 percent and the interview response rate was 68.6 percent. A more stable and experienced field interviewer (FI) workforce improved these rates in 2000. Of the 182,576 eligible households sampled for the 2000 NHSDA main study, 169,769 were successfully screened, for a weighted screening response rate of 92.8 percent (Table B.2). In these screened households, a total of 91,961 sample persons were selected, and completed interviews were obtained from 71,764 of these sample persons, for a weighted interview response rate of 73.9 percent (Table B.3). A total of 10,109 (15.0 percent) sample persons were classified as refusals, 4,834 (5.5 percent) were not available or never at home, and 5,254 (5.5 percent) did not participate for various other reasons, such as physical or mental incompetence or language barrier. Tables B.4 and B.5 show the distribution of the selected sample by interview code and age group. The weighted interview response rate was highest among 12 to 17 year olds (82.6 percent), females (75.1 percent), blacks and Hispanics (76.2 and 78.0 percent, respectively), in nonmetropolitan areas (77.6 percent), and among persons residing in the South (76.4 percent) (Table B.6).

 

Table B.2 Weighted Percentages and Sample Sizes for 1999 and 2000 NHSDAs, by Screening Result Code

Screening Result

1999 NHSDA

 

2000 NHSDA

Sample Size

Weighted Percentage

 

Sample Size

Weighted Percentage

Total Sample

223,868

100.00

 

215,860

100.00

    Ineligible cases

36,026

15.78

 

33,284

15.09

    Eligible cases

187,842

84.22

 

182,576

84.91

Ineligibles

36,026

100.00

 

33,284

100.00

    Vacant

18,034

49.71

 

16,796

50.76

    Not a primary residence

4,516

12.90

 

4,506

13.26

    Not a dwelling unit

4,626

12.70

 

3,173

9.33

    All military personnel

482

1.22

 

414

1.21

    Other, ineligible

8,368

23.46

 

8,395

25.43

Eligible Cases

187,842

100.00

 

182,576

100.00

    Screening complete

169,166

89.63

 

169,769

92.84

      No one selected

101,537

54.19

 

99,999

55.36

      One selected

44,436

23.63

 

46,981

25.46

      Two selected

23,193

11.82

 

22,789

12.03

    Screening not complete

18,676

10.37

 

12,807

7.16

      No one home

4,291

2.38

 

3,238

1.82

      Respondent unavailable

651

0.36

 

415

0.24

      Physically or mentally incompetent

419

0.24

 

310

0.16

      Language barrier—Hispanic

102

0.06

 

83

0.05

      Language barrier—other

486

0.28

 

434

0.27

      Refusal

11,097

5.92

 

7,535

4.14

      Other, access denied

1,536

1.08

 

748

0.45

      Other, eligible

38

0.02

 

7

0.00

      Other, problem case

56

0.03

 

37

0.02

Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 1999 and 2000.

 

Table B.3 Weighted Percentages and Sample Sizes for 1999 and 2000 NHSDAs, by Final Interview Code, among Persons Aged 12 or Older

Final Interview Code

1999 NHSDA

 

2000 NHSDA

Sample Size

Weighted Percentage

 

Sample Size

Weighted Percentage

Total Selected Persons

89,883

100.00

 

91,961

100.00

Interview complete

66,706

68.55

 

71,764

73.93

No one at dwelling unit

1,795

2.13

 

1,776

2.02

Respondent unavailable

3,897

4.53

 

3,058

3.52

Breakoff

50

0.07

 

72

0.09

Physically/mentally incompetent

1,017

2.62

 

1,053

2.57

Language barrier—Spanish

168

0.12

 

109

0.08

Language barrier—Other

480

1.46

 

441

1.06

Refusal

11,276

17.98

 

10,109

14.99

Parental refusal

2,888

1.01

 

2,655

0.88

Other

1,606

1.53

 

924

0.86

Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 1999 and 2000.

 

Table B.4 Weighted Percentages and Sample Sizes for 1999 and 2000 NHSDAs, by Final Interview Code, among Youths Aged 12 to 17

Final Interview Code

1999 NHSDA

 

2000 NHSDA

Sample Size

Weighted Percentage

 

Sample Size

Weighted Percentage

Total Selected Persons

32,011

100.00

 

31,242

100.00

Interview complete

25,384

78.07

 

25,756

82.58

No one at dwelling unit

322

1.09

 

278

0.86

Respondent unavailable

872

3.04

 

617

2.05

Breakoff

13

0.03

 

18

0.05

Physically/mentally incompetent

244

0.76

 

234

0.76

Language barrier—Spanish

15

0.03

 

10

0.03

Language barrier—Other

58

0.18

 

50

0.20

Refusal

1,808

5.97

 

1,455

4.52

Parental refusal

2,885

9.50

 

2,641

8.35

Other

410

1.33

 

183

0.59

Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 1999 and 2000.

 

Table B.5 Weighted Percentages and Sample Sizes for 1999 and 2000 NHSDAs, by Final Interview Code, among Persons Aged 18 or Older

Final Interview Code

1999 NHSDA

 

2000 NHSDA

Sample Size

Weighted Percentage

 

Sample Size

Weighted Percentage

Total Selected Persons

57,872

100.00

 

60,719

100.00

Interview complete

41,322

67.41

 

46,008

72.92

No one at dwelling unit

1,473

2.25

 

1,498

2.16

Respondent unavailable

3,025

4.71

 

2,441

3.69

Breakoff

37

0.07

 

54

0.09

Physically/mentally incompetent

773

2.85

 

819

2.78

Language barrier—Spanish

153

0.13

 

99

0.09

Language barrier—Other

422

1.62

 

391

1.16

Refusal

9,468

19.41

 

8,654

16.22

Parental refusal

3

0.00

 

14

0.01

Other

1,196

1.55

 

741

0.89

Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 1999 and 2000.

 

Table B.6 Response Rates and Sample Sizes for the 1999 and 2000 NHSDAs, by Demographic Characteristics

 

1999 NHSDA

 

2000 NHSDA

Selected Persons

Completed Interviews

Weighted
Response
Rate

 

Selected Persons

Completed Interviews

Weighted Response Rate

Total

89,883

66,706

68.55%

 

91,961

71,764

73.93%

Age in Years

             

    12-17

32,011

25,384

78.07%

 

31,242

25,756

82.58%

    18-25

30,439

22,151

71.21%

 

29,424

22,849

77.34%

    26 or older

27,433

19,171

66.76%

 

31,295

23,159

72.17%

Gender

             

    Male

43,883

31,987

67.12%

 

44,899

34,375

72.68%

    Female

46,000

34,719

69.81%

 

47,062

37,389

75.09%

Race/Ethnicity

             

    Hispanic

11,203

8,755

74.59%

 

11,454

9,396

77.95%

    Non-Hispanic, white

63,211

46,272

67.98%

 

64,517

49,631

73.39%

    Non-Hispanic, black

10,552

8,044

70.39%

 

10,740

8,638

76.19%

    Non-Hispanic, all other races

4,917

3,635

59.28%

 

5,250

4,099

67.31%

Region

             

    Northeast

16,794

11,830

64.03%

 

18,959

14,394

71.68%

    Midwest

24,885

18,103

69.63%

 

25,428

19,355

73.23%

    South

27,390

21,018

70.93%

 

27,217

22,041

76.38%

    West

20,814

15,755

67.47%

 

20,357

15,974

72.68%

County Type

             

    Large metropolitan

36,101

25,901

65.15%

 

37,754

28,744

71.77%

    Small metropolitan

30,642

22,612

69.98%

 

31,400

24,579

74.96%

    Nonmetropolitan

23,140

18,193

74.97%

 

22,807

18,441

77.58%

Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 1999 and 2000.

The increase in nonresponse between the 1998 and 1999 NHSDAs can be attributed primarily to the hiring of many new and inexperienced FIs in 1999 and a larger than usual turnover. By the end of 2000, the interviewer workforce primarily consisted of experienced interviewers, with fewer FIs leaving for other jobs. In 1999, there were 1,997 FIs hired and trained to conduct the CAI and paper-and-pencil interviewing (PAPI) surveys. More than a third of them did not complete the survey year (37.7 percent). In 2000, the number of trained interviewers decreased to 1,356 (because only CAI interviews were conducted in 2000), and the attrition rate dropped to 29.8 percent. Both prior NHSDA experience and on-the-job experience were shown to be related to nonresponse. Previously experienced interviewers and interviewers with one, two, or three quarters of on-the-job experience were more successful at obtaining an interview.

The overall weighted response rate, defined as the product of the weighted screening response rate and weighted interview response rate, was 61.5 percent in 1999 and 68.6 percent in 2000 (an 11.5 percent improvement over the 1999 rate). Nonresponse bias can be expressed as the product of the response rate (R) and the difference between the characteristic of interest between respondents and nonrespondents in the population (Pr - Pnr). Thus, assuming the quantity (Pr - Pnr) is fixed over time, the improvement in response rates in 2000 should result in estimates with lower nonresponse bias.

B.3.2 Inconsistent Responses and Item Nonresponse

Among survey participants, item response rates were above 98 percent for most questionnaire items. However, inconsistent responses for some items, including the drug use items, were common. Estimates of substance use from the NHSDA are based on the responses to multiple questions by respondents, so that the maximum amount of information is used in determining whether a respondent is classified as a drug user. Inconsistencies in responses are resolved through a logical editing process that involves some judgment on the part of survey analysts and is a potential source of nonsampling error. Because of the automatic routing through the CAI questionnaire (e.g., lifetime drug use questions that skip entire modules when answered "no"), there is less editing of this type than in the PAPI questionnaire used in previous years.

In addition, less logical editing is used because with the CAI data, statistical imputation is relied upon more heavily to determine the final values of drug use variables in cases where there is the potential to use logical editing to make a determination. The combined amount of editing and imputation in the CAI data is still considerably less than the total amount used in prior PAPI surveys. For the 2000 CAI data, for example, 3.2 percent of the estimate of past month hallucinogen use is based on logically edited cases and 5.4 percent on imputed cases, for a combined amount of 8.6 percent. For the 1999 CAI data, 1.7 percent of the estimate of past month hallucinogen use is based on logically edited cases and 4.6 percent on imputed cases, for a combined amount of 6.2 percent. In the 1998 NHSDA (administered using PAPI), the amount of editing and imputation for past month hallucinogen use was 60 and 0 percent, respectively, for a total of 60 percent. The combined amount of editing and imputation for the estimate of past month heroin use is 5.0 percent for the 2000 CAI, 14.8 percent for the 1999 CAI, and 37.0 percent for the 1998 PAPI data.

B.3.3 Validity of Self-Reported Use

NHSDA estimates are based on self-reports of drug use, and their value depends on respondents' truthfulness and memory. Although many studies have generally established the validity of self-report data and the NHSDA procedures were designed to encourage honesty and recall, some degree of underreporting is assumed (Harrell, 1997; Harrison & Hughes, 1997; Rouse, Kozel, & Richards, 1985). No adjustment to NHSDA data is made to correct for this. The methodology used in the NHSDA has been shown to produce more valid results than other self-report methods (e.g., by telephone) (Aquilino, 1994; Turner, Lessler, & Gfroerer, 1992). However, comparisons of NHSDA data with data from surveys conducted in classrooms suggest that underreporting of drug use by youths in their homes may be substantial (Gfroerer, 1993; Gfroerer, Wright, & Kopstein, 1997). The results of several studies indicate that underreporting of drug use increases as the social stigma associated with the drug increases (Cisin & Parry, 1980, as cited in Harrell, 1997). Because estimates of drug dependence and abuse are generally associated with a higher level social stigma than drug use, these estimates may be underreported more than the estimates of drug use. In the same study cited by Harrell (1997), failure to report treatment was not associated with the level of stigma attached to the drug at the time of admission. However, when responses on treatment received from former drug treatment clients were compared with their treatment records, almost half denied ever receiving treatment.

A study to validate the dependence and abuse questions currently in the NHSDA has been designed. This study will compare estimates of dependence and abuse using the current NHSDA questions administered using ACASI with the measures from a structured clinical interview. Interviewing for the study will begin in 2002.

Table Of Contents
This is the page footer.

This page was last updated on June 16, 2008.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

Yellow Line

Site Map | Contact Us | Accessibility Privacy PolicyFreedom of Information ActDisclaimer  |  Department of Health and Human ServicesSAMHSAWhite HouseUSA.gov

* Adobe™ PDF and MS Office™ formatted files require software viewer programs to properly read them. Click here to download these FREE programs now

What's New

Highlights Topics Data Drugs Pubs Short Reports Treatment Help Mail OAS